Event | Aspart vs lispro | Glulisine vs lispro | Glulisine vs aspart |
---|---|---|---|
Total Mortality | 1.10 [0.84, 1.44] | 0.61 [0.37, 1.02] | 0.56 [0.36, 0.87] |
CHD | 1.02 [0.83, 1.26] | 1.09 [0.78, 1.52] | 1.06 [0.81, 1.40] |
Fatal CHD | 1.18 [0.74, 1.89] | 0.85 [0.38, 1.90] | 0.72 [0.37, 1.40] |
CVD | 0.95 [0.78, 1.14] | 0.98 [0.72, 1.33] | 1.04 [0.80, 1.34] |
Fatal CVD | 1.15 [0.75, 1.78] | 0.76 [0.36, 1.61] | 0.66 [0.35, 1.23] |
Stroke | 0.86 [0.56, 1.33] | 0.28 [0.11, 0.71]* | 0.32 [0.14, 0.76]* |
Heart Failure | 0.97 [0.75, 1.25] | 0.74 [0.47, 1.18] | 0.77 [0.51, 1.15] |
Kidney Failure | 0.78 [0.58, 1.06] | 0.68 [0.38, 1.22] | 0.87 [0.52, 1.46] |
Hypoglycaemia | 2.37 [1.07, 5.25]* | 3.24 [1.12, 9.42]* | 1.37 [0.65, 2.88] |
Hyperglycaemia | 4.67 [1.49, 14.65]* | 0.39 [0.09, 1.64] | 0.39 [0.09, 1.64] |